More from the Author

• Supplement | HBS Case Collection | September 2019

  Teaming Up to Win the Rail Deal at GE (B)

  Amy Edmondson, Ranjay Gulati and Rachna Tahilyani

  Citation:

  Edmondson, Amy, Ranjay Gulati, and Rachna Tahilyani. "Teaming Up to Win the Rail Deal at GE (B)." Harvard Business School Supplement 420-059, September 2019.  View Details

  CiteView Details

  Related

• Case | HBS Case Collection | September 2019

  Teaming Up To Win The Rail Deal At GE (A)

  Amy Edmondson, Ranjay Gulati and Rachna Tahilyani

  In 2012, Nalin Jain, then head of GE aviation for South Asia, was given the added responsibility for GE’s transportation business in India, including bidding for a $2.5 billion contract to manufacture, service and maintain 1,000 diesel locomotives for state owned Indian Railways (IR). The deal, which would have been “the largest deal on the planet” for the transportation business, had been under discussion for six years, and many within GE had given up hope that it would materialize, but Jain persisted. In February 2015, when IR requested companies to submit a financial bid in six months, Jain quickly built an autonomous team, sequestered from the rest of GE, with people from multiple businesses and functions. His team overcame internal resistance from people at headquarters and stiff competition to help GE win the deal by a narrow margin. Jain was then tasked with executing the deal. As many of his earlier team members had moved on, Jain hired new people and built a new diverse yet integrated team for execution, with members able to put aside their many differences, look beyond their functional silos, and focus on the project deliverables. However, 2017 brought a series of challenges. GE changed India’s organization structure, making India business leaders report only to their respective global business leaders instead of reporting to both their business leaders and the India country leader. Jain’s mandate was expanded to include the entire international operations of GE’s transportation business. And, sub-optimal company performance forced GE to announce cost cuts of $2 billion. In the face of this turmoil, Jain wonders, “Have I created an agile team that can succeed in GE’s matrix environment and deal with the internal challenges? Do the team members have the maturity and motivation required for the project to succeed?”

  Keywords: Recruitment; Selection and Staffing; Human Capital; Leadership Style; Leading Change; Organizational Design; Organizational Structure; Industrial Products Industry; Manufacturing Industry; Rail Industry; Transportation Industry; United States; India;

  Citation:

  Edmondson, Amy, Ranjay Gulati, and Rachna Tahilyani. "Teaming Up To Win The Rail Deal At GE (A)." Harvard Business School Case 420-058, September 2019.  View Details

  CiteView DetailsEducators

  Related

• Case | HBS Case Collection | February 2019 (Revised September 2019)

  Theranos: The Unicorn that Wasn't

  Joseph B. Fuller and John Masko

  In 2003, 19-year-old Elizabeth Holmes founded a startup dedicated to making blood testing easier and more affordable. By 2015, her company, Theranos, was worth $9 billion. It boasted a star-studded board and contracts with national pharmacy and supermarket chains Walgreens and Safeway to bring Theranos technology, which could purportedly perform hundreds of tests with a pinprick of blood, to consumers around the country. Over the next few years, however, Wall Street Journal reporter John Carreyrou published a series of articles demonstrating that Theranos’ proprietary technology produced inaccurate results, relied heavily on non-proprietary devices to perform its tests, and violated multiple regulatory standards. In 2018, after a three-year stream of revelations about the company’s operating practices, corporate culture, and technology, the U.S. Securities and Exchange Commission charged Theranos with fraud and the company soon collapsed.

  Keywords: Theranos; blood; lab testing; fraud; Holmes; Balwani; Shultz; Carreyrou; Securities and Exchange Commission; Food and Drug Administration; FDA; SEC; Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Medical Devices and Supplies Industry;

  Citation:

  Fuller, Joseph B., and John Masko. "Theranos: The Unicorn that Wasn't." Harvard Business School Case 319-068, February 2019. (Revised September 2019.)  View Details

  CiteView DetailsEducatorsPurchase

  Related